Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

Share Finance Facility

15 Sep 2005 08:00

ReGen Therapeutics PLC15 September 2005 ReGen Therapeutics Plc Date 15 September 2005 Committed Share Finance Facility ReGen Therapeutics Plc ("ReGen" or the "Company") announces that on 14thSeptember 2005 it entered into an agreement with the Headstart Group of funds ("Headstart") under which Headstart will make available to the Company acommitted share finance facility of up to Β£2,000,000 (the "Headstart Facility"). Pursuant to the terms of the Headstart Facility, Headstart has agreed, whencalled upon by the Company, to subscribe for, or purchase, new ordinary sharesin the capital of the Company ("Ordinary Shares") to the value of up to, inaggregate, Β£2,000,000. The Headstart Facility is available at any time up to 3years from the date a Committed Share Finance Facility Agreement is entered intoby the Company and Headstart and can be drawn down by the Company in incrementsof up to Β£50,000. The subscription price for an Ordinary Share shall be equalto 95% of the lowest closing bid price of an Ordinary Share in the fifteentrading days following the date on which the Company notifies Headstart that itwishes to make a draw down under the Headstart Facility. In consideration for Headstart making available the Headstart Facility, theCompany has agreed to pay Headstart a one-off underwriting commission of Β£60,000payable by the issue of Ordinary Shares (on the basis of an agreed value perOrdinary Share of 1.35p, being the closing bid price on Wednesday 7th September2005). Β£30,000 of the underwriting commission was payable upon entering into theHeadstart Facility and the remaining Β£30,000 is payable on the first anniversarythereafter. Accordingly, application has been made for 2,222,222 OrdinaryShares to be admitted to trading on the AIM market. It is expected thatadmission to listing will become effective and that dealings in these shareswill commence on Tuesday 20th September 2005. In addition, the Company hasagreed, subject to shareholder approval, to issue warrants granting Headstartthe right to subscribe for up to 4,000,000 Ordinary Shares at a subscriptionprice of 1.65p per share, being a price equal to 110% of the closing bid priceof the Company's shares on 13th September 2005. Such warrants will beexercisable at any time on or before 14th September 2008. As the issue of theWarrants is subject to shareholder approval, ReGen will shortly send toshareholders a circular containing a notice convening an extraordinary generalmeeting of the Company (the "Circular") for 10.00 a.m. on 10 October 2005 (the "EGM") containing resolutions to, inter alia, approve the issue of the Warrants. Copies of the Circular will be available, for collection only, free of charge tothe public, from the Company, Suite 406, Langham House, 29-30 Margaret Street,London W1W 8SA during normal office hours on any day (Saturdays, Sundaysexcepted) from 19 September 2005 until 14 October 2005. - For further information, please contact:Andrew MarshallMarshall Robinson RoeTel No 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Nov 20157:00 amRNSAppointment of Non-Executive Director
30th Oct 20157:00 amRNSExercise of Warrants & Issue of Equity
30th Sep 20157:00 amRNSHalf Yearly Report
30th Jun 201512:48 pmRNSResult of AGM
5th Jun 20157:00 amRNSFinal Results and Notice of AGM
7th May 20154:40 pmRNSSecond Price Monitoring Extn
7th May 20154:35 pmRNSPrice Monitoring Extension
7th May 20157:10 amRNSDirectorate Change
7th May 20157:05 amRNSElection to U.S. National Academy of Sciences
7th May 20157:00 amRNSLicences new anti-cancer stem cell technology
21st Apr 20157:00 amRNSIssue of convertible loan notes and warrants
31st Mar 20157:00 amRNSPlacing to raise £2.55 million
20th Mar 20157:00 amRNSExercise of Options and Issue of Equity
3rd Mar 20157:00 amRNSGrant of Options
26th Jan 20157:00 amRNSGrant of Options
23rd Jan 20152:04 pmRNSBoard changes
20th Jan 20157:00 amRNSLicenses milciclib from Nerviano Medical Sciences
22nd Dec 20147:00 amRNSRe Agreement with Novimmune
31st Mar 20149:00 amRNSSchedule 1 - Alexander David Investments plc
31st Mar 20147:31 amRNSRestoration - Alexander David Investments plc
19th Dec 20133:00 pmRNSSuspension - Alexander David Investments Plc
30th Aug 20137:30 amRNSRestoration - Alexander David Investments plc
19th Apr 20137:30 amRNSSuspension - Alexander David Investments Plc
1st May 20124:25 pmRNSReplacement: Holding(s) in Company
30th Apr 20122:46 pmRNSHolding(s) in Company
2nd Apr 20123:32 pmRNSHolding(s) in Company
12th Mar 20122:45 pmRNSHolding(s) in Company
17th Dec 200910:13 amRNSUSA Sales Update
1st Oct 200910:34 amRNSPRG Nutraceuticals UK Launch
1st Jul 20095:10 pmRNSHolding(s) in Company
30th Jun 20095:41 pmRNSHolding(s) in Company
30th Jun 20092:27 pmRNSAudited Accounts, Notice of AGM & TVR
23rd Jun 20097:00 amRNSIssue of Equity
17th Jun 20093:49 pmRNSHolding(s) in Company
16th Jun 20094:15 pmRNSPreliminary Results
15th Jun 20095:06 pmRNSHolding(s) in Company
12th Jun 200912:05 pmRNSIssue of Equity
10th Jun 20093:39 pmRNSShareholding
4th Jun 20097:00 amRNSIssue of Equity
2nd Jun 20092:52 pmRNSHolding(s) in Company
2nd Jun 200912:50 pmRNSColostrinin Distribution in Poland
20th May 20095:28 pmRNSShareholding
5th May 20094:50 pmRNSHolding(s) in Company
5th May 200912:56 pmRNSShareholding in Company
30th Apr 20092:08 pmRNSTotal Voting Rights
28th Apr 20094:24 pmRNSHolding(s) in Company
24th Apr 20094:35 pmRNSIssue of Equity
22nd Apr 200912:10 pmRNSHolding(s) in Company
17th Apr 20093:47 pmRNSShareholding
15th Apr 20097:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.